Liver Cancer Awareness: Understanding Your Risks, Recognizing the Signs, and Protecting Your Liver
By Rodrico Gordon, DNP-C, AGPCNP-BC, NE-BC
Founder and Clinical Director, Gordon Wellness Service
October 15, 2026
Watch the short video above for a quick overview of liver cancer awareness and why your health matters.
Introduction: Why Liver Cancer Awareness Matters
October is Liver Cancer Awareness Month, an opportunity to raise awareness about a serious disease that often develops without noticeable symptoms during its early stages.
The liver is one of the body's most vital organs. It performs hundreds of essential functions, including processing nutrients, removing harmful substances from the bloodstream, producing proteins necessary for blood clotting, and supporting digestion.
Despite its remarkable ability to regenerate, the liver remains vulnerable to chronic inflammation, metabolic disorders, viral infections, and cancer.
Liver cancer represents a significant global public health concern. Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, frequently develops in individuals with underlying chronic liver disease. Early identification of risk factors, preventive interventions, and appropriate surveillance are essential components of reducing liver cancer-related complications and mortality (Singal et al., 2023).
At Gordon Wellness Service, we believe that understanding your health risks and taking proactive steps toward prevention can make a meaningful difference in your long-term health.
Understanding Liver Cancer
Liver cancer occurs when abnormal cells develop and multiply uncontrollably within the liver.
The most common form of primary liver cancer is hepatocellular carcinoma, which originates in hepatocytes, the liver's primary functional cells.
Another form, intrahepatic cholangiocarcinoma, develops in the bile ducts located within the liver.
It is important to distinguish primary liver cancer from metastatic liver cancer. Metastatic liver cancer occurs when cancer cells spread to the liver from another organ, such as the colon, pancreas, or lungs.
Hepatocellular carcinoma accounts for the majority of primary liver cancers, and its development is strongly associated with chronic liver inflammation, fibrosis, and cirrhosis (Singal et al., 2023).
Understanding these underlying conditions is essential because liver cancer prevention frequently begins with identifying and managing chronic liver disease.
Who Is at Increased Risk for Liver Cancer?
Several medical conditions, environmental exposures, and lifestyle factors can increase an individual's risk of developing liver cancer.
1. Chronic Hepatitis B and Hepatitis C
Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major risk factors for hepatocellular carcinoma.
These infections can cause persistent liver inflammation, progressive fibrosis, and cirrhosis.
Importantly, individuals with chronic hepatitis B may develop liver cancer even without cirrhosis.
Appropriate hepatitis screening, hepatitis B vaccination, and antiviral treatment are important preventive strategies. Successful hepatitis C treatment substantially reduces liver cancer risk, although some individuals with advanced liver disease continue to require surveillance after treatment (Singal et al., 2023).
2. Cirrhosis
Cirrhosis is a condition characterized by extensive scarring of liver tissue resulting from long-term liver injury.
Common causes include chronic viral hepatitis, alcohol-associated liver disease, and advanced metabolic liver disease.
Cirrhosis is one of the strongest risk factors for hepatocellular carcinoma.
Individuals with cirrhosis may benefit from routine liver cancer surveillance, depending on their overall health, liver function, and eligibility for potential treatment (Singal et al., 2023).
3. Metabolic Dysfunction-Associated Steatotic Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease, is increasingly recognized as an important contributor to chronic liver disease.
MASLD is frequently associated with obesity, type 2 diabetes, hypertension, and abnormal cholesterol levels.
Some individuals develop metabolic dysfunction-associated steatohepatitis (MASH), which involves liver inflammation and may progress to fibrosis or cirrhosis.
Although liver cancer can occasionally develop in patients with MASLD who do not have cirrhosis, routine liver cancer surveillance is not recommended for every individual with fatty liver disease. Surveillance decisions depend on the severity of liver disease and other clinical factors (Singal et al., 2023).
4. Excessive Alcohol Consumption
Long-term excessive alcohol consumption can contribute to chronic liver inflammation, fibrosis, and cirrhosis.
Alcohol-associated liver disease is an established risk factor for hepatocellular carcinoma, particularly when advanced liver scarring develops.
Reducing alcohol consumption and avoiding alcohol when medically indicated can help prevent additional liver injury (Singal et al., 2023).
5. Additional Risk Factors
Other factors associated with increased liver cancer risk include:
Cigarette smoking
Certain inherited liver disorders
Exposure to aflatoxins, toxins produced by specific molds
A family history of hepatocellular carcinoma
Older age and male sex
Certain metabolic conditions, including type 2 diabetes
Having one or more risk factors does not mean an individual will develop liver cancer. However, identifying these risks can help healthcare professionals determine appropriate preventive and monitoring strategies.
Recognizing the Warning Signs
One of the greatest challenges associated with liver cancer is that early-stage disease frequently produces no noticeable symptoms.
When symptoms do develop, they may include:
Unexplained weight loss
Persistent fatigue or weakness
Loss of appetite
Pain or discomfort in the upper right abdomen
Abdominal swelling
Nausea or vomiting
Feeling unusually full after eating small meals
Yellowing of the skin or eyes, known as jaundice
Dark urine or pale-colored stools
These symptoms are not specific to liver cancer and may occur with other medical conditions.
Nevertheless, persistent or unexplained symptoms should be evaluated by a healthcare professional.
The absence of symptoms does not eliminate the possibility of liver disease or liver cancer, particularly in individuals with established risk factors (Singal et al., 2023).
The Importance of Early Detection and Surveillance
Early detection plays an important role in improving treatment opportunities for individuals diagnosed with liver cancer.
When hepatocellular carcinoma is identified at an early stage, potentially curative treatment options may include surgical resection, liver transplantation, or local ablative therapies.
Unfortunately, liver cancer may remain undetected until more advanced stages, when treatment options become limited.
For this reason, the American Association for the Study of Liver Diseases (AASLD) recommends regular surveillance for selected individuals at increased risk.
What Does Liver Cancer Surveillance Involve?
For eligible patients, surveillance generally includes:
Liver ultrasound: A noninvasive imaging examination used to evaluate the liver for suspicious abnormalities.
Alpha-fetoprotein (AFP) testing: A blood test that may help identify potential liver cancer when used alongside imaging.
According to Singal et al. (2023), surveillance using abdominal ultrasound and AFP testing approximately every six months is recommended for appropriate at-risk populations.
However, AFP testing alone is not sufficiently reliable to diagnose or exclude liver cancer.
Patients with inadequate ultrasound visualization or suspicious findings may require additional imaging, such as multiphase computed tomography or magnetic resonance imaging.
It is important to distinguish surveillance from diagnostic testing. Surveillance is performed regularly in selected high-risk individuals who do not have symptoms, whereas diagnostic testing evaluates suspicious symptoms, laboratory findings, or imaging abnormalities.
Not everyone requires liver cancer surveillance. A healthcare professional should assess each patient's medical history, liver disease severity, and individual risk factors.
Can Liver Cancer Be Prevented?
Although not every case of liver cancer can be prevented, several evidence-based strategies can reduce the risk of developing chronic liver disease and hepatocellular carcinoma.
1. Know Your Hepatitis Status
Hepatitis B and hepatitis C infections may remain undiagnosed for years because many individuals experience few or no symptoms.
Screening allows healthcare professionals to identify infections and initiate appropriate treatment or monitoring.
Adults should discuss recommended hepatitis screening with their healthcare professional, particularly if they have never been tested.
2. Receive Recommended Hepatitis B Vaccination
Hepatitis B vaccination is an effective strategy for preventing HBV infection and reducing the risk of associated liver complications.
Vaccination recommendations depend on factors such as age, vaccination history, and individual risk.
3. Maintain a Healthy Weight
Maintaining a healthy weight through balanced nutrition and regular physical activity can help reduce metabolic risk factors associated with fatty liver disease.
Individuals with obesity, diabetes, or other metabolic conditions may benefit from individualized weight management and chronic disease treatment plans.
4. Limit Alcohol Consumption
Excessive alcohol consumption contributes to liver injury and increases the risk of cirrhosis.
Reducing alcohol intake, or abstaining when medically recommended, supports liver health.
5. Avoid Tobacco Products
Smoking is associated with increased cancer risk, including liver cancer.
Smoking cessation provides substantial benefits for overall health and reduces exposure to cancer-causing substances.
6. Manage Chronic Medical Conditions
Appropriate management of diabetes, obesity, hypertension, and abnormal cholesterol levels can help reduce the risk of progressive metabolic liver disease.
Preventive care and ongoing monitoring are particularly important for individuals with multiple metabolic risk factors.
7. Follow Recommended Liver Disease Monitoring
Individuals diagnosed with chronic hepatitis, cirrhosis, or other significant liver disorders should maintain regular follow-up with their healthcare professionals.
Treatment adherence, laboratory monitoring, and appropriate cancer surveillance can help identify complications and support timely intervention.
These preventive strategies are consistent with evidence-based recommendations for reducing liver disease progression and hepatocellular carcinoma risk (Singal et al., 2023).
Why Preventive Healthcare Matters
Preventive healthcare provides an opportunity to identify potential health concerns before complications develop.
Many conditions associated with liver cancer, including chronic hepatitis and metabolic liver disease, may progress without obvious symptoms.
Routine healthcare visits allow clinicians to evaluate relevant medical history, identify risk factors, review recommended vaccinations, and determine whether screening or additional testing is appropriate.
For individuals with known liver disease, ongoing follow-up can help assess disease progression and determine whether specialist evaluation or liver cancer surveillance is necessary.
Prevention is not simply about avoiding illness. It is about recognizing risks early and taking informed steps to protect your health.
How Gordon Wellness Service Can Help
At Gordon Wellness Service, we emphasize preventive healthcare, chronic disease management, and patient education as essential components of long-term wellness.
Our approach focuses on helping adults understand their health risks and make informed healthcare decisions.
Through comprehensive health evaluations, appropriate laboratory testing, management of chronic medical conditions, and coordination with specialists when indicated, we work with patients to identify potential health concerns and support overall wellness.
For patients with chronic hepatitis, suspected advanced liver disease, or increased liver cancer risk, referral to a gastroenterologist or hepatologist may be appropriate.
Our goal is to encourage proactive healthcare and empower patients with the knowledge needed to participate actively in their care.
Final Thoughts: Protecting Your Liver Starts With Awareness
Liver Cancer Awareness Month serves as an important reminder that serious liver conditions can develop without obvious warning signs.
Understanding your personal risk factors, addressing chronic liver disease, maintaining healthy lifestyle habits, and participating in recommended surveillance can make a meaningful difference.
Although liver cancer cannot always be prevented, early identification of risk factors and appropriate medical management may reduce the likelihood of serious complications.
At Gordon Wellness Service, we encourage patients to remain informed, proactive, and engaged in their healthcare.
Your liver works hard for you every day. Taking steps to protect it is an investment in your long-term health.
Take the Next Step Toward Better Liver Health
Are you concerned about your liver health, chronic medical conditions, or preventive healthcare needs?
At Gordon Wellness Service, we provide individualized adult healthcare services focused on prevention, education, and chronic disease management.
Schedule a healthcare visit to discuss your health concerns and determine which preventive services may be appropriate for you.
Gordon Wellness Service
Empowering Healthier Lives Through Education and Preventive Care
Website: https://www.rose-hall-wellness.com/
Phone: (929) 813-3548
Email: info@rose-hall-wellness.com
References
Colli, A., Nadarevic, T., Miletic, D., Giljaca, V., Fraquelli, M., Štimac, D., & Casazza, G. (2021). Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews, 2021(4), Article CD013346. https://doi.org/10.1002/14651858.CD013346.pub2
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., Mendiratta-Lala, M., Brown, D. B., Rilling, W. S., Goyal, L., Wei, A. C., & Taddei, T. H. (2023). AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology, 78(6), 1922–1965. https://doi.org/10.1097/HEP.0000000000000466
Both publications are peer-reviewed, and their bibliographic details have been verified. Icahn School of Medicine at Mount Sinai
Medical Disclaimer
This article is intended for educational and informational purposes only. It does not replace individualized medical advice, diagnosis, or treatment. Individuals experiencing symptoms or concerned about their liver health should consult a qualified healthcare professional.
